Works matching IS 0167594X AND DT 2019 AND VI 143 AND IP 3


Results: 26
    1
    2
    3
    4
    5
    6

    Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
    By:
    • Jaeckle, Kurt A.;
    • Anderson, S. K.;
    • Twohy, Erin L.;
    • Dixon, Jesse G.;
    • Giannini, Caterina;
    • Jenkins, Robert;
    • Egorin, Merrill J.;
    • Sarkaria, Jann N.;
    • Brown, Paul D.;
    • Flynn, P. J.;
    • Schwerkoske, John;
    • Buckner, Jan C.;
    • Galanis, Evanthia
    Publication type:
    Article
    7
    8

    Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 417, doi. 10.1007/s11060-019-03192-1
    By:
    • Vora, Parvez;
    • Seyfrid, Mathieu;
    • Venugopal, Chitra;
    • Qazi, Maleeha A.;
    • Salim, Sabra;
    • Isserlin, Ruth;
    • Subapanditha, Minomi;
    • O'Farrell, Erin;
    • Mahendram, Sujeivan;
    • Singh, Mohini;
    • Bakhshinyan, David;
    • Chokshi, Chirayu;
    • McFarlane, Nicole;
    • Dvorkin-Gheva, Anna;
    • Brown, Kevin R.;
    • Murty, Naresh;
    • Moffat, Jason;
    • Bader, Gary D.;
    • Singh, Sheila K.
    Publication type:
    Article
    9
    10

    The case for radiosurgery for brainstem metastases.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 585, doi. 10.1007/s11060-019-03195-y
    By:
    • Winograd, Evan;
    • Rivers, Charlotte I.;
    • Fenstermaker, Robert;
    • Fabiano, Andrew;
    • Plunkett, Robert;
    • Prasad, Dheerendra
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 447, doi. 10.1007/s11060-019-03175-2
    By:
    • Pedretti, Sara;
    • Masini, Laura;
    • Turco, Enrico;
    • Triggiani, Luca;
    • Krengli, Marco;
    • Meduri, Bruno;
    • Pirtoli, Luigi;
    • Borghetti, Paolo;
    • Pegurri, Ludovica;
    • Riva, Nada;
    • Gatta, Roberto;
    • Fusco, Vincenzo;
    • Scoccianti, Silvia;
    • Bruni, Alessio;
    • Ricardi, Umberto;
    • Santoni, Riccardo;
    • Magrini, Stefano M.;
    • Buglione, Michela
    Publication type:
    Article
    26